0001209191-23-049781.txt : 20230918 0001209191-23-049781.hdr.sgml : 20230918 20230918170712 ACCESSION NUMBER: 0001209191-23-049781 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230915 FILED AS OF DATE: 20230918 DATE AS OF CHANGE: 20230918 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Emany Sravan Kumar CENTRAL INDEX KEY: 0001897662 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34620 FILM NUMBER: 231261810 MAIL ADDRESS: STREET 1: 100 SUMMER ST STREET 2: SUITE 2300 CITY: BOSTON STATE: MA ZIP: 02109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IRONWOOD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001446847 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043404176 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 SUMMER STREET, SUITE 2300 CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 617-621-7722 MAIL ADDRESS: STREET 1: 100 SUMMER STREET, SUITE 2300 CITY: BOSTON STATE: MA ZIP: 02110 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-09-15 0 0001446847 IRONWOOD PHARMACEUTICALS INC IRWD 0001897662 Emany Sravan Kumar C/O IRONWOOD PHARMACEUTICALS, INC. 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 0 1 0 0 SVP, Chief Financial Officer 0 Class A Common Stock 2023-09-15 4 P 0 36072 8.32 A 188730 D The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.31 to $8.33, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. /s/ Brian Tessler, Attorney-in-Fact 2023-09-18